Deborah Mukherji· @dmukherji · X·· 2 days agoScore70
Body
Promising data in locally advanced penile cancer at #ESMO26!
Neoadjuvant toripalimab + TIP achieved 84% ORR and 48% pCR in a phase II study (n=25). @OncoAlert #HuiHan
148 views · 2 likes · 2 reposts · 0 replies
Conference abstracts
Neoadjuvant toripalimab combined with chemotherapy for locally advanced penile squamous cell carcinoma: A multicenter prospective, single-arm, phase II clinical trial
https://esmocongress.esmo.orgSource: Deborah Mukherji · x.com